• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Amboy Street Ventures Launches $20M Fund to Support Femtech Startups

by Jasmine Pennic 03/15/2023 Leave a Comment

Amboy Street Ventures Launches $20M Fund to Support Femtech Startups

What You Should Know:

– Amboy Street Ventures, the world’s first venture capital firm focused on women’s health and sexual health for all genders, closed its debut $20 million fund.

– Amboy Street plans to invest in the Seed and Series A stages of women’s health and sexual health startups to both lift associated stigmas and usher forward a new world of inclusive health and wellbeing. 

Investment Thesis & Portfolio

The world is undergoing a massive social reformation which is lifting the taboos and stigmas that surround Women’s Health & Sexual Health. Amboy Street Ventures invests in startups that are creating the vital technology that meets the Sexual Health and Women’s Health needs of our progressive society. Amboy Street was founded by investor and former engineer Carli Sapir and is supported by General Partners Dominique Karetsos and Dr. Maria Godoy, leaders in the women’s and sexual health industry.

Amboy Street is backed by predominantly female Limited Partners who are driving the world’s leading financial institutions: 10+ Partners and Directors from Goldman Sachs, JP Morgan, and Bank of America; Founders of prominent funds including Summit Partners and First Round Capital; Senior Executives at top Hedge Funds and Private Equity funds including Fortress Investment Group and Citadel; Successful Founders; and Planned Parenthood Executives.

Amboy Street has already invested in eight startups and realized its first exit as Gennev (a telehealth and product line for menopausal women) was acquired by Unified Women’s Healthcare.

Amboy Street current investment portfolio include:

– Evvy – vaginal microbiome testing and care

– Hey Jane – telehealth abortion access

– Contraline – male birth control

– Dame Products – female-focused sexual pleasure products

– HerMD – telehealth and brick-and-mortar menopause and sexual health services

– Aunt Flow – free menstrual products for more than 19,000 bathrooms nationwide

– Dipsea – audio erotica subscription app 

“Amboy Street’s hands-on approach helped us gain access to the resources, tools and partners we needed,” said Alexandra Fine, CEO of Dame Products. “They believed in our vision with conviction, and we are proud to be included in this new fund.”

Tagged With: Femtech, Health Startups, microbiome, Partners, Private Equity, telehealth, venture capital, Vital

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |